Why US health care expenditure and ranking on health care indicators are so different from Canada's

被引:15
作者
Spithoven, A. H. G. M. [1 ]
机构
[1] Utrecht Sch Econ, NL-3512 BL Utrecht, Netherlands
来源
INTERNATIONAL JOURNAL OF HEALTH CARE FINANCE & ECONOMICS | 2009年 / 9卷 / 01期
关键词
Health care expenditure; United States; Canada; UNITED-STATES; DEFENSIVE MEDICINE; COSTS; PHYSICIANS; INCOME; DETERMINANTS; PERSPECTIVE; COUNTRIES; SERVICES; ALCOHOL;
D O I
10.1007/s10754-008-9044-0
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
Compared to other industrialized countries, the U.S. spends most of all on health care. Nonetheless, the U.S. ranks relatively low on health care indicators. This paradox has been already known for decades. For example, the turning point comparing the U.S. and Canada was in 1972. Health expenditure as a percentage of GDP was higher in Canada than in the USA from 1960 until 1972. Since 1972 expenditure on health care has been higher in the U.S. than in Canada (OECD 2005a, Health data 2005, fourteenth OECD electronic database on health systems, date of release June 2005, last update 04/26/2005). The present study integrates the dispersed literature on spending and health care rankings and adds some statistical analysis to these studies. The evaluation of different factors influencing health care expenditure in the U.S. relative to other countries is restricted to a comparison with Canada. The U.S. and Canada are two countries that are sufficiently similar to make comparisons useful. The comparison of factors influencing health care expenditure in the U.S. and Canada in 2002 reveals that health care expenditure in the U.S. is higher than in Canada mainly due to administration costs, Baumol's cost disease and pharmaceutical prices. It is not primarily inefficiency in health care production but the dominant prevalence for free choice and own responsibility that explains the paradox of high expenditure on health care and low ranking on health care indicators.
引用
收藏
页码:1 / 24
页数:24
相关论文
共 102 条
[1]   Consumed in theory: Alternative perspectives on the economics of consumption [J].
Ackerman, F .
JOURNAL OF ECONOMIC ISSUES, 1997, 31 (03) :651-664
[2]  
*AIR, 2003, MED MAPR INS STABL L
[3]   Health spending in the United States and the rest of the industrialized world [J].
Anderson, GF ;
Hussey, PS ;
Frogner, BK ;
Waters, HR .
HEALTH AFFAIRS, 2005, 24 (04) :903-914
[4]   It's the prices, stupid: Why the United States is so different from other countries [J].
Anderson, GF ;
Reinhardt, UE ;
Hussey, PS ;
Petrosyan, V .
HEALTH AFFAIRS, 2003, 22 (03) :89-105
[5]   Health spending, access, and outcomes: Trends in industrialized countries [J].
Anderson, GF ;
Poullier, JP .
HEALTH AFFAIRS, 1999, 18 (03) :178-192
[6]   Excess in the pharmaceutical industry [J].
Angell, M .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (12) :1451-1453
[7]   Lowering generic drug prices - Less regulation equals more competition [J].
Anis, AH ;
Guh, DP ;
Woolcott, J .
MEDICAL CARE, 2003, 41 (01) :135-141
[8]  
[Anonymous], 2003, HEALTH AFFAIR
[9]  
[Anonymous], 2005, WORLD DEV IND DAT
[10]  
[Anonymous], 11303 NBER